Brief: Histogen Announces Preliminary Week 18 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men

Histogen

01/12/2020 13:21

Dec 1 (Reuters) - Histogen Inc  HSTO.O :
    * HISTOGEN ANNOUNCES PRELIMINARY WEEK 18 HST-001 STUDY
RESULTS FOR
THE TREATMENT OF ANDROGENIC ALOPECIA IN MEN
    * HISTOGEN INC - HST-001 DEMONSTRATED SEPARATION FROM
PLACEBO AT
WEEK 18 PRIMARY EFFICACY ENDPOINT ASSESSMENT
    * HISTOGEN INC - HST-001 FOUND TO BE SAFE AND WELL TOLERATED
WITH
NO SERIOUS ADVERSE EVENTS
    * HISTOGEN INC - WEEK 26 FINAL STUDY RESULTS FOR HST-001
EXPECTED
IN EARLY Q1 OF 2021

Source text for Eikon:  ID:nGNX7bK5tZ 
Further company coverage:  HSTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))